Older Hodgkin’s Lymphoma Patients May Have Treatment Option to Standard Chemotherapy
News
Results from a recent Phase 2 study revealed that brentuximab vedotin monotherapy may provide a frontline treatment option for older patients with Hodgkin’s lymphoma (HL) who are unable to tolerate standard combination ... Read more